Israel Englander Senti Biosciences, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.36 - $0.66 $388 - $711	-1,078 Reduced 7.48%	13,337 $5,000
Q4 2023 Feb 14, 2024	BUY	$0.28 - $0.68 $4,036 - $9,802	14,415 New	14,415 $9,000
Q4 2022 Feb 14, 2023	SELL	$1.25 - $65.2 $26,243 - $1.37 Million	-20,995 Reduced 48.06%	22,694 $32,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $21.7 $9,931 - $162,033	7,467 Added 20.61%	43,689 $95,000

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.